Vanda Pharmaceuticals

This study is testing whether a medication called iloperidone can help lower blood pressure in people whose hypertension isn't controlled by their current medications. Researchers will compare iloperidone against a placebo in 240 participants over 4 weeks. The goal is to see if t…

This study is testing whether adding a new drug called milsaperidone to standard antidepressants helps people with major depression who aren't getting enough relief. It will involve 500 adults whose current depression treatment isn't working well enough. Researchers will compare …

This study is testing whether a long-acting injection of the medication iloperidone can help prevent symptom flare-ups in people with schizophrenia. It will compare the injection to a placebo (a dummy shot) in 400 adults who are already stable on treatment. The main goal is to se…

This early-stage study is testing the safety and side effects of an experimental drug called trichostatin A in adults with blood cancers that have returned or stopped responding to standard treatments. The main goal is to find the highest dose patients can tolerate without severe…

This study is testing whether a medication called tasimelteon can help people with delayed sleep-wake phase disorder, a condition where their natural sleep schedule is shifted very late. About 70 adults with this diagnosis will take either the study drug or a placebo pill daily. …

This study is testing whether a new eye drop called VSJ-110 is safe and effective at relieving dry eye symptoms. About 160 adults with dry eye will use the drops or a placebo for eight weeks. Researchers will measure changes in eye dryness and irritation to see if the new treatme…

This study is testing whether a single dose of an experimental medication called VQW-765 can quickly reduce anxiety during stressful social situations. About 500 adults with social anxiety disorder will take either the medication or a placebo before a public speaking test. Resear…